某院病区口服抗糖尿病药物用药的规范性评价  

Evaluation of Standardized Usage of Oral Antidiabetic Agents in Inpatients' Prescriptions

作　　者：李毅梅 徐婷 徐倩 徐斌 

机构地区：[1]上海交通大学医学院附属瑞金医院北院药剂科,上海200025

出　　处：《中国药师》2018年第1期125-128,共4页China Pharmacist

摘　　要：目的:评价某院病区口服抗糖尿病药物医嘱的规范性,为合理用药提供依据。方法:采取回顾性调查方法,查阅2017年1~3月病区口服抗糖尿病药物的长期医嘱,统计分析药物使用情况,评价医嘱规范性。结果:病区口服抗糖尿病药物13个品种,医嘱4 397条,医嘱方案886条,盐酸二甲双胍片和阿卡波糖片使用频率最高;医嘱用药不规范率70.54%,其中"未标注准确的用药时间"占66.03%,"标注错误的用药时间"占4.51%。12种药品存在不规范问题(>50%)。结论:医嘱开具的主要问题是未考虑到抗糖尿病药物的服用时间点,既影响最佳疗效,也不利依从性用药,因此必须规范此类药物的医嘱开具,提高药物治疗方案的规范性。Objective： To evaluate the standardized usage of oral antidiabetic agents in inpatients to provide reference for the pre- scription standardization. Methods： A retrospective study was used to evaluate the prescriptions of oral antidiabetic agents in inpatients during January and March in 2017, and statistical analysis was conducted on drug usage and standardization evaluation. Results： There were 886 medication plans including g,397 prescriptions, which involved in 13 kinds of antidiabetic agents. Mefformin and acarbose a- gents were used most frequently. The non-standardization rate was 70.54% with 66. 03% unlabeled accurate time for oral administra- tion and 4.51% labeled wrong time for oral administration. Twelve antidiabetic agents existed non-standardized applications （ 〉 50% ）. Conclusion： The main problem in the non-standardized usage of antidiabetic agents is leaving the special time for oral adminis- tration of antidiabetic agents out of account, which not only affect the best efficacy, but also reduce patients＇ compliance. It＇ s neces- sary to standardize the prescriptions of antidiabetic agents to improve the standardization of medication therapy.

关 键 词：口服抗糖尿病药物 医嘱 规范性 合理用药 

分 类 号：R969.3[医药卫生—药理学]